FDA “black box” labeling☆

Office of Drug Evaluation II, Center for Drug Evaluation and Research, US Food and Drug Administration, Rockville, MD.

Address for correspondence: Robert J. Meyer, MD, Office of Drug Evaluation II, Center for Drug Evaluation and Research, US Food and Drug Administration, 5600 Fishers Lane, Room 13B-28, HFD-102, Rockville, MD 20857; 301-827-5920, fax 301-480-6644; E-mail meyerro@cder.fda.gov

• Abstract
• Full Text
• PDF
• References